Author

Michael Vieth 1

1 Klinikum Bayreuth Abt. Pathology,Bayreuth,Germany

A novel budesonide orodispersible tablet with a special esophageal-targeting can induce complete clinical, endoscopic and histologic remission in active Eosinophilic Esophagitis: Results from a post-hoc analysis of the randomized, double-blind, placebo-controlled EOS-1 trial

Stephan Miehlke, Christoph Schlag, Alex Straumann, Michael Vieth, Ralph Mueller, Roland Greinwald, Alfredo J. Lucendo

A novel oral budesonide formulation is highly effective for induction of remission in patients with active eosinophilic esophagitis: Results from the 6-weeks open-label treatment phase of EOS-2 trial

Alfredo J. Lucendo, Christoph Schlag, Stephan Miehlke, Luc Biedermann, Cecilio Santander Vaquero, Dirk Hartmann, Jamal Hayat, Petr Hruz, Constanza Ciriza De Los Ríos, Arjan Bredenoord, Michael Vieth, Ralph Müller, Roland Greinwald, Alex Straumann

A NOVEL, INTERACTIVE WEB-BASED EDUCATIONAL TOOL IMPROVES DETECTION AND DELINEATION OF BARRETT’S OESOPHAGUS RELATED NEOPLASIA (BORN): THE BORN PROJECT.

Jacques J. Bergman, Oliver Pech, Krish Ragunath, David Armstrong, Guido Tytgat, John Dent, Lars Lundell, Michael Vieth, Prateek Sharma

A PROSPECTIVE COHORT STUDY EVALUATING NAVIAID AB - A NOVEL PLATFORM FOR DEEP SMALL BOWEL ENTEROSCOPY

Helmut Neumann, Klaus Mönkemüller, Gian E. Tontini, Martin Grauer, Michael Vieth, Lucia Fry, Markus F. Neurath

A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, EUROPEAN MULTICENTRE TRIAL OF TWO NEW BUDESONIDE FORMULATIONS FOR TREATMENT OF ACTIVE EOSINOPHILIC ESOPHAGITIS

Petr Hruz, Stephan Miehlke, Ulrike von Arnim, Ahmed Madisch, Michael Vieth, Christiane Fibbe, Henning Wittenburg, Hans-Dieter Allescher, Max Reinshagen, Stefan Schubert, Jan Tack, Michaela Müller, Alexander J. Eckardt, Patrick Krummenerl, Joris Arts, Karin Dilger, Roland Greinwald, Alex Straumann

A RARE CASE OF COLLAGENOUS GASTRITIS IN A 16 YEAR OLD MALE PATIENT

Corinna Lang-Schwarz, Sebastian Haag, Theresa Dregelies, Michael Vieth, Johanna Wehleit

ACCURACY OF THE FULL SPECTRUM ENDOSCOPY (FUSE) SYSTEM FOR ASSESSMENT OF DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASES (IBD) COMPARED TO HIGH-DEFINITION ENDOSCOPY

Helmut Neumann, Gian E. Tontini, Andreas Nägel, Timo Rath, Michael Vieth, Martin Grauer, Klaus Mönkemüller, Markus F. Neurath

ACCURACY OF THE FULL SPECTRUM ENDOSCOPY SYSTEM (FUSE) FOR PREDICTION OF COLORECTAL POLYP HISTOLOGY ACCORDING TO THE REQUIREMENTS OF THE PIVI STATEMENT

Helmut Neumann, Gian E. Tontini, Michael Vieth, Klaus Mönkemüller

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Ralph Mueller, Christoph Schlag, Christoph Schmöcker, Roland Greinwald, Luc Biedermann, Michael Vieth, Alfredo J. Lucendo, Cecilio Santander, Alex Straumann, Petr Hruz, Ahmed Madisch, Stephan Miehlke, Stephen E. Attwood, Arjan Bredenoord, Stefan Schubert, Constanza Ciriza De Los Ríos, Alain M. Schoepfer, Jamal Hayat, Ulri

Budesonide orodispersible tablets are superior to maintain combined clinical and histological remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Luc Biedermann, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Stefan Schubert, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen

Item 1 - 10 / 100
1
2 3 4 5 6 7
...
9 10